Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids
…“K2”). These SCBs were largely outlawed in the U.S., but blanket policies that placed all SCB chemicals into restrictive control categories impeded research progress into novel mechanisms for SCB therapeutic…
